Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Concentrix Corp Director's Dealing 2023

Oct 11, 2023

31393_dirs_2023-10-11_13439014-6816-43e8-be8d-af8a5ca4116b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Concentrix Corp (CNXC)
CIK: 0001803599
Period of Report: 2023-10-09

Reporting Person: POLK DENNIS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-10-09 Common Stock M 14201 $37.94 Acquired 30494 Direct
2023-10-09 Common Stock M 4416 $48.14 Acquired 34910 Direct
2023-10-09 Common Stock M 812 $64.21 Acquired 35722 Direct
2023-10-09 Common Stock S 13247 $80.981 Disposed 22475 Direct
2023-10-09 Common Stock S 6182 $81.617 Disposed 16293 Direct
2023-10-11 Common Stock M 1183 $37.94 Acquired 17476 Direct
2023-10-11 Common Stock S 1183 $81.3894 Disposed 16293 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-10-09 Employee Stock Option (Right to Buy) $37.94 M 14201 Disposed 2028-10-11 Common Stock (14201) Direct
2023-10-09 Employee Stock Option (Right to Buy) $48.14 M 4416 Disposed 2028-04-09 Common Stock (4416) Direct
2023-10-09 Employee Stock Option (Right to Buy) $64.21 M 812 Disposed 2027-10-03 Common Stock (812) Direct
2023-10-11 Employee Stock Option (Right to Buy) $37.94 M 1183 Disposed 2028-10-11 Common Stock (1183) Direct

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.46 to $81.455, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.46 to $81.97, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The stock option vested as to 20% of the shares on October 11, 2019 and vested as to 1/60th of the shares monthly thereafter.

F4: The stock option vested as to 20% of the shares on October 3, 2018 and vested as to 1/60th of the shares monthly thereafter.